
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
---|---|---|---|---|---|---|
Revenue | $3.2B | $3.1B | $3.8B | $4.2B | $4.7B | |
Revenue Growth (YoY) | -4.21% | -2.15% | 21.66% | 9.64% | 12.61% | |
Cost of Revenues | $2.6B | $2.6B | $3.2B | $3.4B | $3.8B | |
Gross Profit | $557.2M | $496.6M | $648.2M | $813.8M | $932.1M | |
Gross Profit Margin | 17.42% | 15.87% | 17.02% | 19.49% | 19.82% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $259.8M | $262.4M | $293.5M | $327.7M | $393M | |
Other Inc / (Exp) | -$32.6M | $4.4M | $10.2M | $21.6M | $28.2M | |
Operating Expenses | $435.7M | $415.1M | $437.7M | $490.8M | $591.6M | |
Operating Income | $121.5M | $81.6M | $210.5M | $323M | $340.5M | |
Net Interest Expenses | $29.7M | $33.2M | $40.6M | $52.6M | $61M | |
EBT. Incl. Unusual Items | $59.2M | $52.8M | $180.1M | $292M | $307.8M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $24.9M | $4.2M | $37.9M | $73.1M | $74.4M | |
Net Income to Company | $34.3M | $48.6M | $142.2M | $218.9M | $233.4M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $34.3M | $48.6M | $142.2M | $218.9M | $233.4M | |
Basic EPS (Cont. Ops) | $1.08 | $1.60 | $4.81 | $7.46 | $8.02 | |
Diluted EPS (Cont. Ops) | $1.07 | $1.57 | $4.74 | $7.37 | $7.92 | |
Weighted Average Basic Share | $31.7M | $30.3M | $29.5M | $29.3M | $29.1M | |
Weighted Average Diluted Share | $32.1M | $30.8M | $30M | $29.7M | $29.5M | |
EBITDA | $264.8M | $238.6M | $364.9M | $507.7M | $567.4M | |
EBIT | $88.9M | $85.9M | $220.7M | $344.6M | $368.8M | |
Revenue (Reported) | $3.2B | $3.1B | $3.8B | $4.2B | $4.7B | |
Operating Income (Reported) | $121.5M | $81.6M | $210.5M | $323M | $340.5M | |
Operating Income (Adjusted) | $88.9M | $85.9M | $220.7M | $344.6M | $368.8M |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Revenue | $727.5M | $876.3M | $1B | $1.1B | $1.3B | |
Revenue Growth (YoY) | -10.66% | 20.45% | 19.31% | 9.27% | 10.17% | |
Cost of Revenues | $620M | $745.7M | $853.4M | $921.6M | $1B | |
Gross Profit | $107.5M | $130.6M | $192.1M | $220.8M | $247.5M | |
Gross Profit Margin | 14.78% | 14.9% | 18.38% | 19.33% | 19.66% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $67M | $69.4M | $82.4M | $94.6M | $103.7M | |
Other Inc / (Exp) | $3.1M | $5.9M | $5M | $9.3M | $7.3M | |
Operating Expenses | $106.1M | $106M | $119.6M | $139.8M | $162.1M | |
Operating Income | $1.4M | $24.6M | $72.5M | $81M | $85.4M | |
Net Interest Expenses | $6.4M | $10.2M | $11.4M | $12.8M | $14M | |
EBT. Incl. Unusual Items | -$1.8M | $20.2M | $66.1M | $77.4M | $78.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$2.7M | $694K | $14.6M | $14.9M | $17.6M | |
Net Income to Company | $898K | $19.5M | $51.5M | $62.6M | $61M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $898K | $19.5M | $51.5M | $62.6M | $61M | |
Basic EPS (Cont. Ops) | $0.03 | $0.66 | $1.75 | $2.15 | $2.11 | |
Diluted EPS (Cont. Ops) | $0.03 | $0.65 | $1.73 | $2.12 | $2.09 | |
Weighted Average Basic Share | $30.7M | $29.6M | $29.4M | $29.1M | $28.9M | |
Weighted Average Diluted Share | $31.3M | $30.1M | $29.8M | $29.6M | $29.3M | |
EBITDA | $43.1M | $66M | $114.7M | $135.5M | $151M | |
EBIT | $4.1M | $29.3M | $77.5M | $90.3M | $92.6M | |
Revenue (Reported) | $727.5M | $876.3M | $1B | $1.1B | $1.3B | |
Operating Income (Reported) | $1.4M | $24.6M | $72.5M | $81M | $85.4M | |
Operating Income (Adjusted) | $4.1M | $29.3M | $77.5M | $90.3M | $92.6M |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Revenue | $3.1B | $3.3B | $4B | $4.3B | $4.8B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $2.6B | $2.8B | $3.3B | $3.4B | $3.9B | |
Gross Profit | $530.5M | $519.7M | $709.7M | $842.4M | $958.8M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $260.9M | $264.8M | $306.5M | $339.9M | $402.2M | |
Other Inc / (Exp) | $9.4M | $7.1M | $9.3M | $25.9M | $26.3M | |
Operating Expenses | $430M | $415M | $451.3M | $510.9M | $614M | |
Operating Income | $100.5M | $104.7M | $258.5M | $331.5M | $344.9M | |
Net Interest Expenses | $22.8M | $37M | $41.8M | $54.1M | $62.2M | |
EBT. Incl. Unusual Items | $87.1M | $74.8M | $226M | $303.3M | $308.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $19.5M | $7.6M | $51.8M | $73.4M | $77M | |
Net Income to Company | $67.7M | $67.2M | $174.2M | $230M | $231.9M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $67.7M | $67.2M | $174.2M | $230M | $231.9M | |
Basic EPS (Cont. Ops) | $2.13 | $2.24 | $5.90 | $7.85 | $7.97 | |
Diluted EPS (Cont. Ops) | $2.10 | $2.21 | $5.82 | $7.76 | $7.89 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $279.3M | $261.5M | $413.7M | $528.4M | $582.9M | |
EBIT | $110.2M | $111.2M | $268.9M | $357.4M | $371.2M | |
Revenue (Reported) | $3.1B | $3.3B | $4B | $4.3B | $4.8B | |
Operating Income (Reported) | $100.5M | $104.7M | $258.5M | $331.5M | $344.9M | |
Operating Income (Adjusted) | $110.2M | $111.2M | $268.9M | $357.4M | $371.2M |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Revenue | $727.5M | $876.3M | $1B | $1.1B | $1.3B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $620M | $745.7M | $853.4M | $921.6M | $1B | |
Gross Profit | $107.5M | $130.6M | $192.1M | $220.8M | $247.5M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $67M | $69.4M | $82.4M | $94.6M | $103.7M | |
Other Inc / (Exp) | $3.1M | $5.9M | $5M | $9.3M | $7.3M | |
Operating Expenses | $106.1M | $106M | $119.6M | $139.8M | $162.1M | |
Operating Income | $1.4M | $24.6M | $72.5M | $81M | $85.4M | |
Net Interest Expenses | $6.4M | $10.2M | $11.4M | $12.8M | $14M | |
EBT. Incl. Unusual Items | -$1.8M | $20.2M | $66.1M | $77.4M | $78.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | -$2.7M | $694K | $14.6M | $14.9M | $17.6M | |
Net Income to Company | $898K | $19.5M | $51.5M | $62.6M | $61M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $898K | $19.5M | $51.5M | $62.6M | $61M | |
Basic EPS (Cont. Ops) | $0.03 | $0.66 | $1.75 | $2.15 | $2.11 | |
Diluted EPS (Cont. Ops) | $0.03 | $0.65 | $1.73 | $2.12 | $2.09 | |
Weighted Average Basic Share | $30.7M | $29.6M | $29.4M | $29.1M | $28.9M | |
Weighted Average Diluted Share | $31.3M | $30.1M | $29.8M | $29.6M | $29.3M | |
EBITDA | $43.1M | $66M | $114.7M | $135.5M | $151M | |
EBIT | $4.1M | $29.3M | $77.5M | $90.3M | $92.6M | |
Revenue (Reported) | $727.5M | $876.3M | $1B | $1.1B | $1.3B | |
Operating Income (Reported) | $1.4M | $24.6M | $72.5M | $81M | $85.4M | |
Operating Income (Adjusted) | $4.1M | $29.3M | $77.5M | $90.3M | $92.6M |
Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $11.8M | $310.8M | $224.2M | $101.1M | $92.7M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $367.5M | $351.1M | $400.2M | $511.6M | $573.4M | |
Inventory | $70.8M | $81.3M | $115M | $108.6M | $127.3M | |
Prepaid Expenses | $14.8M | $14.6M | $17.4M | $20.1M | $20.7M | |
Other Current Assets | $12.8M | $14.1M | $19.6M | $20.2M | $11.3M | |
Total Current Assets | $1.2B | $1.4B | $1.5B | $1.6B | $1.7B | |
Property Plant And Equipment | $337.1M | $355.9M | $435.1M | $521.3M | $654.1M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $272.5M | $272.5M | $272.5M | $312M | $330.3M | |
Other Intangibles | $119.3M | $101.8M | $86.6M | $109M | $219.7M | |
Other Long-Term Assets | $8M | $9.3M | $9.4M | $14.7M | $38.3M | |
Total Assets | $1.9B | $2.1B | $2.3B | $2.5B | $2.9B | |
Accounts Payable | $159M | $155.9M | $207.7M | $222.1M | $223.5M | |
Accrued Expenses | $108.3M | $112.4M | $111.2M | $107.5M | $118.3M | |
Current Portion Of Long-Term Debt | $81.7M | $17.5M | $17.5M | $17.5M | $10M | |
Current Portion Of Capital Lease Obligations | $24.8M | $24.6M | $27.5M | $32M | $35.8M | |
Other Current Liabilities | $21.3M | $25.7M | $26.7M | $32.5M | $34.1M | |
Total Current Liabilities | $448.5M | $381.8M | $469.6M | $506.3M | $587.2M | |
Long-Term Debt | $501.6M | $823.3M | $807.4M | $791.4M | $933.2M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.1B | $1.4B | $1.4B | $1.5B | $1.7B | |
Common Stock | $10.2M | $9.9M | $9.8M | $9.7M | $9.7M | |
Other Common Equity Adj | -- | -$1.8M | -$1.8M | -$1.5M | -- | |
Common Equity | $811.3M | $758.5M | $868.8M | $1.1B | $1.2B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $811.3M | $758.5M | $868.8M | $1.1B | $1.2B | |
Total Liabilities and Equity | $1.9B | $2.1B | $2.3B | $2.5B | $2.9B | |
Cash and Short Terms | $11.8M | $310.8M | $224.2M | $101.1M | $92.7M | |
Total Debt | $583.3M | $840.8M | $824.9M | $808.9M | $943.2M |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $330.6M | $185.6M | $71.4M | $26.1M | $16.1M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $342.6M | $387.8M | $438.6M | $513M | $621.1M | |
Inventory | $71.1M | $94.1M | $115.7M | $104M | $133M | |
Prepaid Expenses | $31.5M | $30.3M | $31.2M | $32M | $32.4M | |
Other Current Assets | $15M | $15.4M | $20.4M | $21M | $10.4M | |
Total Current Assets | $1.5B | $1.4B | $1.5B | $1.6B | $1.8B | |
Property Plant And Equipment | $340.5M | $361.1M | $447.1M | $538.7M | $679.4M | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $272.5M | $272.5M | $272.5M | $315.3M | $330.5M | |
Other Intangibles | $114.6M | $97.9M | $83.1M | $108.5M | $207.8M | |
Other Long-Term Assets | $6.8M | $10.1M | $10.1M | $14.1M | $49.9M | |
Total Assets | $2.3B | $2.1B | $2.3B | $2.6B | $3.1B | |
Accounts Payable | $171M | $176.4M | $196.2M | $212.9M | $259.2M | |
Accrued Expenses | $120.4M | $127.9M | $119.4M | $125.1M | $126.2M | |
Current Portion Of Long-Term Debt | $61.5M | $17.5M | $17.5M | $17.5M | $15M | |
Current Portion Of Capital Lease Obligations | $25M | $24.5M | $28.6M | $32.9M | $38.2M | |
Other Current Liabilities | $27.8M | $19.8M | $20.9M | $28.2M | $29.9M | |
Total Current Liabilities | $436.1M | $395.7M | $433.1M | $513.6M | $631.8M | |
Long-Term Debt | $835.2M | $819.3M | $803.4M | $842.4M | $1B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.5B | $1.4B | $1.4B | $1.5B | $1.8B | |
Common Stock | $10.3M | $9.8M | $9.8M | $9.7M | $9.6M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $810M | $758.3M | $897.4M | $1.1B | $1.3B | |
Total Liabilities and Equity | $2.3B | $2.1B | $2.3B | $2.6B | $3.1B | |
Cash and Short Terms | $330.6M | $185.6M | $71.4M | $26.1M | $16.1M | |
Total Debt | $896.7M | $836.8M | $820.9M | $859.9M | $1B |
Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $34.3M | $48.6M | $142.2M | $218.9M | $233.4M | |
Depreciation & Amoritzation | $175.9M | $152.7M | $144.2M | $163.1M | $198.6M | |
Stock-Based Compensation | $12.8M | $9.9M | $17.9M | $25.5M | $40.3M | |
Change in Accounts Receivable | $11.9M | $136.3M | -$173.7M | -$142.4M | -$117.8M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $381.8M | $308.7M | $164.8M | $259M | $349.1M | |
Capital Expenditures | $58M | $157M | $201M | $218.5M | $250.5M | |
Cash Acquisitions | -- | -- | -$350K | -$122.9M | -$183.9M | |
Cash From Investing | -$44.6M | -$151.7M | -$183.9M | -$306.2M | -$395.2M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $1.1B | $595M | -- | $763M | $987.4M | |
Long-Term Debt Repaid | -$1.4B | -$330.1M | -$17.5M | -$780.5M | -$852.4M | |
Repurchase of Common Stock | -$100M | -$106.1M | -$48.7M | -$49.7M | -$65.6M | |
Other Financing Activities | $6.5M | -$18.3M | -$5.8M | -$9.9M | -$23.7M | |
Cash From Financing | -$383.4M | $142M | -$67.4M | -$75.9M | $37.7M | |
Beginning Cash (CF) | $59.9M | $13.6M | $312.6M | $226M | $102.9M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$46.3M | $299M | -$86.6M | -$123.1M | -$8.4M | |
Ending Cash (CF) | $13.6M | $312.6M | $226M | $102.9M | $94.5M | |
Levered Free Cash Flow | $323.7M | $151.6M | -$36.2M | $40.5M | $98.6M |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $898K | $19.5M | $51.5M | $62.6M | $61M | |
Depreciation & Amoritzation | $39.1M | $36.6M | $37.3M | $45.2M | $58.4M | |
Stock-Based Compensation | $3.7M | $3.1M | $6.6M | $7.8M | $9.1M | |
Change in Accounts Receivable | $12.4M | -$110.7M | -$127M | -$124M | -$174.2M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $41.5M | -$64.9M | -$85.1M | -$37.4M | -$54M | |
Capital Expenditures | $31.6M | $38.4M | $42.9M | $42M | $79.5M | |
Cash Acquisitions | -- | -- | -- | -$13M | -- | |
Cash From Investing | -$28.6M | -$33M | -$33.6M | -$42.2M | -$68.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $595M | -- | -- | $120M | $285M | |
Long-Term Debt Repaid | -$271.9M | -$4.4M | -$4.4M | -$69.4M | -$196M | |
Repurchase of Common Stock | -- | -$18.5M | -$20.3M | -$29.8M | -$30.2M | |
Other Financing Activities | -$17.6M | -$5.5M | -$9.6M | -$16.3M | -$12.9M | |
Cash From Financing | $305.9M | -$27.2M | -$34.1M | $4.7M | $45.9M | |
Beginning Cash (CF) | $13.6M | $312.6M | $226M | $102.9M | $94.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $318.8M | -$125.2M | -$152.8M | -$74.9M | -$76.7M | |
Ending Cash (CF) | $332.4M | $187.4M | $73.2M | $27.9M | $17.8M | |
Levered Free Cash Flow | $9.9M | -$103.3M | -$128M | -$79.4M | -$133.5M |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $67.7M | $67.2M | $174.2M | $230M | $231.9M | |
Depreciation & Amoritzation | $169.1M | $150.2M | $144.8M | $171M | $211.8M | |
Stock-Based Compensation | $14.2M | $9.3M | $21.4M | $26.7M | $41.6M | |
Change in Accounts Receivable | $92.2M | $13.2M | -$190M | -$139.4M | -$167.9M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $338.1M | $202.2M | $144.6M | $306.7M | $332.5M | |
Capital Expenditures | $69M | $163.8M | $205.5M | $217.5M | $288M | |
Cash Acquisitions | -- | -- | -$350K | -$135.9M | -$170.9M | |
Cash From Investing | -$54.9M | -$156.1M | -$184.5M | -$314.8M | -$421.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $986.7M | -- | -- | $883M | $1.2B | |
Long-Term Debt Repaid | -$1.5B | -$62.6M | -$17.5M | -$845.5M | -$979M | |
Repurchase of Common Stock | -$100M | -$124.7M | -$50.5M | -$59.1M | -$66M | |
Other Financing Activities | -$11.1M | -$6.2M | -$9.8M | -$16.5M | -$20.4M | |
Cash From Financing | -$599.8M | -$191.2M | -$74.2M | -$37.2M | $78.9M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$316.6M | -$145M | -$114.2M | -$45.3M | -$10.1M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $269.2M | $38.4M | -$60.9M | $89.2M | $44.5M |
Period Ending | 2021-04-30 | 2022-04-30 | 2023-04-30 | 2024-04-30 | 2025-04-30 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $898K | $19.5M | $51.5M | $62.6M | $61M | |
Depreciation & Amoritzation | $39.1M | $36.6M | $37.3M | $45.2M | $58.4M | |
Stock-Based Compensation | $3.7M | $3.1M | $6.6M | $7.8M | $9.1M | |
Change in Accounts Receivable | $12.4M | -$110.7M | -$127M | -$124M | -$174.2M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $41.5M | -$64.9M | -$85.1M | -$37.4M | -$54M | |
Capital Expenditures | $31.6M | $38.4M | $42.9M | $42M | $79.5M | |
Cash Acquisitions | -- | -- | -- | -$13M | -- | |
Cash From Investing | -$28.6M | -$33M | -$33.6M | -$42.2M | -$68.6M | |
Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $595M | -- | -- | $120M | $285M | |
Long-Term Debt Repaid | -$271.9M | -$4.4M | -$4.4M | -$69.4M | -$196M | |
Repurchase of Common Stock | -- | -$18.5M | -$20.3M | -$29.8M | -$30.2M | |
Other Financing Activities | -$17.6M | -$5.5M | -$9.6M | -$16.3M | -$12.9M | |
Cash From Financing | $305.9M | -$27.2M | -$34.1M | $4.7M | $45.9M | |
Beginning Cash (CF) | $13.6M | $312.6M | $226M | $102.9M | $94.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $318.8M | -$125.2M | -$152.8M | -$74.9M | -$76.7M | |
Ending Cash (CF) | $332.4M | $187.4M | $73.2M | $27.9M | $17.8M | |
Levered Free Cash Flow | $9.9M | -$103.3M | -$128M | -$79.4M | -$133.5M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.